PTGES and cancer: Inhibiting microsomal prostaglandin E2 synthase‐1 (mPGES‐1), an inducible enzyme involved in prostaglandin E2 (PGE2) biosynthesis and tumor microenvironment (TME) homeostasis, is a valuable strategy for treating inflammation and cancer.